1. Jun M, et al. Lancet 2010 Epub May 10

2. Identification process for eligible studies
Jun M, et al. Lancet 2010 Epub May 10

3. Characteristics of the studies included in the systematic review and meta-analysis – Part I
Jun M, et al. Lancet 2010 Epub May 10

4. Characteristics of the studies included in the systematic review and meta-analysis – Part II
Jun M, et al. Lancet 2010 Epub May 10

5. Effect of fibrates on risk of major cardiovascular outcomes
Jun M, et al. Lancet 2010 Epub May 10

6. Effect of fibrates on the risk of coronary events
Jun M, et al. Lancet 2010 Epub May 10

7. Summary of the relative risks of all outcomes assessed
Jun M, et al. Lancet 2010 Epub May 10

8. Effect of lipid level differences between treatment and placebo groups
Jun M, et al. Lancet 2010 Epub May 10

9. Subgroup analyses for the effects of fibrates on coronary events
Jun M, et al. Lancet 2010 Epub May 10

10. Univariate meta-regression exploring the role of achieved lipid concentrations on the effectiveness of fibrate therapy on coronary events
Jun M, et al. Lancet 2010 Epub May 10